Yet the evidence should not be overinterpreted, as conventional pacing maintains an important role, says Elena Arbelo.
Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...
Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronization, according ...
Left bundle branch area pacing is an effective and practical strategy for cardiac resynchronization, according to a ...
Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra â„¢ ...
BIOTRONIK has unveiled its brand new Edora pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps) following CE Mark approval in Europe. These devices feature BIOTRONIK’s ProMRI ...
Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...
St. Jude Medical announced Monday that the Minnesota device maker received FDA approvals for three new pacemakers. This means that American patients will be able to access its Allure Quadra Cardiac ...
This week Cambridge Consultants unveiled a semi-leadless pacemaker it designed for start-up EBR Systems. The device, called Wireless Cardiac Stimulation system (WiCS), includes a leadless electrode ...
According to BCC Research, the global market is projected to grow at a CAGR of 5.7%, supported by increasing cardiovascular ...
The major trials that established cardiac resynchronization therapy (CRT) as a treatment for heart failure (HF) with reduced ejection fraction (HFrEF) tended not to include patients who already had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results